Hostname: page-component-cb9f654ff-rkzlw Total loading time: 0 Render date: 2025-08-18T16:07:54.025Z Has data issue: false hasContentIssue false

Responsiveness of European countries to the population mental health needs: A cross-national comparison study

Published online by Cambridge University Press:  14 April 2025

Celso Arango
Affiliation:
Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), School of Medicine, Universidad Complutense, Madrid, Spain
Andrea Fiorillo
Affiliation:
Department of Psychiatry, University of Campania “Luigi Vanvitelli”, Naples, Italy
Geert Dom
Affiliation:
Collaborative Antwerp Psychiatric Research Institute (CAPRI), University of Antwerp, Antwerp, Belgium
Javier-David Lopez-Morinigo*
Affiliation:
Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), School of Medicine, Universidad Complutense, Madrid, Spain Department of Psychiatry, Hospital Universitario del Sureste, Arganda del Rey, Madrid, Spain
*
Corresponding author: Javier-David Lopez-Morinigo; Email: javier.lopez@iisgm.com

Abstract

Background

This study aimed to cross-compare European countries’ responsiveness to their populations’ mental health (MH) needs.

Methods

For the EU-27 countries and the United Kingdom, the 2023 Headway Initiative collected data on 15 key performance indicators (KPIs) in responsiveness in healthcare, including workforce, facilities, quality of care, and MH expenditure, and 14 KPIs in responsiveness in workplaces, schools, and society. Bivariate correlations between Headway-transformed KPI scores, which were standardised in a 1–10 Likert Scale (1: worst performance; 10: best performance), tested for putative associations.

Results

Responsiveness in healthcare: Sweden (10), Denmark (8.8), and Finland (8.3) showed the best performance, while Romania (1.0), Slovakia (1.1), and Latvia and Bulgaria (1.2) had the poorest performance. Responsiveness in workplaces: schools, and society, Germany (10.0), France (9.1), and Denmark (9.1) were the most responsive countries, while Greece and Slovakia (1.0) had the poorest responsiveness. MH status total scores negatively correlated with global scores on responsiveness in healthcare (r = −0.34, p = .075), workplaces (r = −0.46, p = .014), schools (r = −0.59, p = .003), and society (r = −0.53, p = .003) – poorer MH status, greater responsiveness.

Conclusions

European countries significantly differed in their responsiveness to the populations’ MH needs, although the real effectiveness of their MH policies remains to be elucidated. Whether more responsive countries, which achieved poorer MH outcomes, successfully met greater preexisting MH needs, they failed to do so, or the relationship is driven by other third variables (e.g., quality of MH assessment) requires future investigation.

Information

Type
Research Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of European Psychiatric Association

Introduction

Despite the ongoing global mental health (MH) crisis, service provision continues to lag behind the need for care [1, 2]. The treatment gap represents a major public health issue [Reference Kohn, Saxena, Levav and Saraceno3, Reference Lora, Kohn, Levav, McBain, Morris and Saxena4], which has widened over time [2]. In 2023, up to 25% of European citizens raised issues about mental healthcare, such as unacceptably long waiting lists, increased treatment costs and lack of information on service provision [5]. Of concern, investment in MH continues to lag behind other medical specialities, such as oncology and cardiology [Reference Olesen6], and remains inequitably distributed within- and between-populations [2, Reference Kirkbride, Anglin, Colman, Dykxhoorn, Jones and Patalay7]. It is true, however, that beyond a certain threshold, increased funding in mental healthcare may not achieve better outcomes, which may require greater social care expenditure [Reference Park, Han, Torabi and Forget8]. In addition, stigma, among other unresolved issues, continues to prevent MH patients from receiving appropriate care [Reference Henderson, Potts and Robinson9Reference Thornicroft, Sunkel, Alikhon Aliev, Baker, Brohan and El Chammay11].

In the first Headway-based article (Lopez-Morinigo et al., this issue), Europeans’ MH status was shown to significantly vary across countries, which was determined by a complex interplay of individual, environmental and social factors. A fundamental question therefore arises: what can be done? In short, two approaches can be adopted. First, universal primary prevention measures addressing the determinants of MH may reduce the incidence of mental disorders [Reference Kirkbride, Anglin, Colman, Dykxhoorn, Jones and Patalay7, Reference Fusar-Poli, Correll, Arango, Berk, Patel and Ioannidis12], which was discussed in depth in the aforementioned article (Lopez-Morinigo et al., this issue). Second, from a secondary/tertiary prevention model, enhancing countries’ responsiveness to people’s MH needs should improve patient outcomes [Reference Priebe and Reininghaus13], which forms the context for this study. In brief, it can be anticipated that both increased MH funding and closer multiagency collaboration across social services, education, labour, and the justice system will be required [14].

In addition, our first Headway-based article in this issue (Lopez-Morinigo et al.) revealed that within the ongoing post-pandemic polycrisis [15], the impact of the determinants of MH differed between European countries, in line with previous reports [5, Reference Fiorillo and Gorwood16, Reference Jones and Ventevogel17]. Somehow surprisingly, the correlation between determinants of MH and the populations’ MH status was found to be weak across Europe, including “high-risk, good MH status” and “low-risk, poor MH status” countries (Lopez-Morinigo et al., this issue). Among other contributors, we speculated that between-country differences in their responsiveness to the population MH needs may partly explain this (Lopez-Morinigo et al., this issue). To test this hypothesis, we carried out the present cross-national comparison study of the EU-27 + UK countries’ responsiveness in healthcare, workplaces, schools, and society to their populations’ MH needs.

Methods

The 2023 Headway mental health index initiative

The Headway Initiative methodology was detailed elsewhere [15] (see also Lopez-Morinigo et al., this issue). Briefly, the 2023 Headway–Mental Health Index 3.0 collected data on 54 key performance indicators (KPIs) across the EU-27 + UK countries, including 14 KPIs in the responsiveness in healthcare and 15 KPIs in the responsiveness in workplaces, schools, and society. Data sources were official, authoritative, open-access datasets (e.g., World Health Organization [WHO]), and KPIs were decided by expert consensus meetings. Not only did this reduce the risk of potential selection bias, but also the use of open-access datasets ensured the replicability of the study, which is imperative in high-quality research.

For each country, KPI scores ranged from 1 (worst performance) to 10 (best performance) depending on the relative performance of each country compared with all other countries, thus making the data comparable across the board (see Lopez-Morinigo et al., this issue, for further details).

Responsiveness in healthcare

Fourteen KPIs (see Table 1) were examined across four major domains: (i) MH workforce – rate of psychiatrists, child neuropsychiatrists, psychologists, and nurses per 100,000 inhabitants; (ii) mental healthcare facilities – rate of hospital beds, child and adolescent psychiatric beds, psychiatric hospitals, psychiatric units in general hospitals, and community-based MH facilities per 100,000 inhabitants; (iii) quality of care, which encompassed rate of hospital discharges from psychiatric wards, MH consultations and published psychiatric articles per 100,000 inhabitants, length of stay, and percentage of surveyed people reporting unmet needs; and (iv) economic resources for MH, measured as the percentage on total healthcare expenditure.

Responsiveness in workplaces, schools, and society

Table 2 details the KPIs in responsiveness in workplaces, schools, and society, the variable(s) included in each KPI, the variable measure, and data source.

In terms of responsiveness in workplaces, we looked at six KPIs, namely the wage gap between people with/without mental disorders, employment rate, sick leave benefits and unemployment benefits of people with mental disorders, job quality or satisfactions, and availability of MH promotion programs in workplaces.

Three KPIs in responsiveness to MH needs in schools were measured: availability of day centers for young people with mental disorders, percentage of youth dropping out of school due to MH issues, and availability of MH promotion programs in schools.

Regarding responsiveness in society, we evaluated six KPIs: availability of social workers and occupational therapists in the MH sector and hospital beds per 100,000 inhabitants, social support (measured as the proportion of people aged 15 years, who self-perceived poor social support), disability benefits for people with mental disorders, and existence of MH promotion programs for the general public.

Statistics

Scores on all KPIs were reported per country, which were ordered alphabetically, including an overall EU-27 + UK average, at a descriptive level. We also ran a set of bivariate correlations between KPI scores to explore potential associations. Since all Headway-transformed KPI scores, which ranged from 1 to 10, followed a normal distribution, Pearson coefficients and the corresponding p-value were reported. Given the exploratory nature of the analyses, no correction for multiple testing techniques were applied to the correlations, which were unadjusted. The Statistical Package for Social Science, version 25.0 (SPSS Inc., Chicago, IL, USA), was used for all the above analyses. The significance level (two-tailed) was set at p < .05.

Results

Responsiveness in healthcare

Headway scores on KPIs in responsiveness in healthcare for the EU-27 + UK countries are detailed in Table 3.

Table 3. Headway initiative scores on key performance indicators in responsiveness in healthcare

Overall, Sweden (10), Denmark (8.8), and Finland (8.3) had the best performance, while Romania (1.0), Slovakia (1.1), Latvia (1.2), and Bulgaria (1.2) had the poorest responsiveness.

In terms of overall workforce, Finland achieved the best performance (10.0), followed by the Netherlands (9.7) and Denmark, (8.3), while Bulgaria (1.0), Portugal (1.9), and Romania (2.0) had the poorest performance. Further details about the full raw data and Headway-transformed scores are provided in Table S1 in the online Supplementary Material.

With regard to facilities, Slovenia (10), Italy (9.9), and Cyprus (9.6) were the more resourced countries, whereas the Netherlands (1.0), Germany (1.5), and Belgium (3.4) had the poorest performance in facilities. The raw data and Headway-transformed scores are detailed in Table S2 (online Supplementary Material).

Regarding quality of care, Denmark (10.0), Ireland (9.4), and Sweden (8.7) showed the highest performance, whereas Romania (1.0), Slovakia (1.4), and Bulgaria and Latvia (1.5) had the poorest quality of care (see Table S3, online Supplementary Material, for further details).

In terms of MH expenditure (see also Table S4, online Supplementary Material), France, Germany, and Sweden spent 13.9, 13.1, and 10.0% of the total health expenditure on MH, respectively. On the other hand, Bulgaria (2%), Estonia (2.9%), and Italy (3.0%) showed the lowest percentage of MH expenditure.

Responsiveness in workplaces, schools, and society

Headway scores on KPIs for responsiveness in workplaces, schools, and society are provided in Table 4.

Table 4. Headway-transformed KPI scores in responsiveness in workplaces, society, and schools

According to the total scores, Germany (10), France (9.1), and Denmark (9.1) achieved the best performance, while Slovakia (1.0), Greece (1.1), and Cyprus (3.5) had the poorest response.

Regarding KPIs in responsiveness in workplaces, Germany (10), Finland, and Belgium (9.4) reached the best performance, while Greece (1.0), Slovakia (1.4), and Czechia and Hungary (3.4) had the poorest response (see also Table S5, online Supplementary Material).

In terms of responsiveness in schools, France (10.0) and Latvia and Lithuania (8.6) had the best performance, whereas Slovakia (1.0), Cyprus (2.2), and Greece (2.4) had the poorest (see also Table S6, online Supplementary Material).

Regarding KPI scores in responsiveness in society, Germany (10), France (9.3), and Sweden (8.6) achieved the highest performance, while Greece (1.0), Estonia (2.0), and Romania (3.1) had the poorest performance (see Table S7 in the online Supplementary Material for further details).

Overall, for KPI scores in responsiveness in non-healthcare, Germany (10), France, and Denmark (9.1) were the most responsive countries, while Slovakia (1.0), Greece (1.0), and Cyprus (3.6) had the lowest scores.

Relationship between MH status and responsiveness of the system

Bivariate correlations between status and determinant KPIs across EU-27 + UK countries are detailed in Table 5. While overall performance on healthcare responsiveness (r = −0.34, p = .075) did not reach statistical significance (although at a borderline level), responsiveness in workplaces (r = −0.46, p = .014), schools (r = −0.59, p < .001), and society (r = −0.53, p = .003) correlated with the overall status – the better the responsiveness, the worse the MH status. Further significant correlations emerged from the analyses (Table 5).

Table 5. Relationship between mental health status and responsiveness across EU-27 + UK countries

In bold, statistically significant (p < .05) correlations.

Overall results

The overall results, including all KPIs in MH status, determinants, and responsiveness to MH needs, are graphically summarized in Figure 1. In particular, those countries in the top-right corner (in green color) achieved the best overall performance in MH-related KPIs, namely Sweden, Finland, and Denmark. Conversely, countries in the bottom-left quadrant (in red color) had the poorest overall performance in MH-related KPIs, such as Greece and Slovakia, although both countries had very good MH status (see bubble dimension, although it is noteworthy that the larger the bubble, the better the MH status), as discussed further below.

Figure 1. Overall results from the 2023 Headway Mental Health Index 3.0.

Discussion

Principal findings

This second Headway-based article revealed a high variation in the responsiveness to MH needs across EU-27 + UK countries, which was shown to negatively correlate with the population MH status – the poorer the MH status, the better the responsiveness. Thus, Sweden, Finland, Denmark, France, and Germany achieved the best performance on responsiveness to their populations’ MH needs, although their performance in MH status was poor. On the other hand, Greece, Slovakia, and Cyprus, which performed well in MH status KPIs, showed the poorest performance in responsiveness to MH needs. At first glance, it seems that countries’ responsiveness failed to mitigate the impact of the determinants of MH. Conversely, one may argue that better-performing countries in responsiveness might do so because of greater preexisting MH needs (e.g., Scandinavian countries) and vice versa (South-European countries). Nevertheless, tackling inequality and bridging the mental healthcare gap should guide future European MH policies.

Responsiveness in healthcare

The WHO defined health systems responsiveness as “how well the health system meets the legitimate expectations of population for non-health enhancing aspects of the health system” [18]; hence, an inherent goal of any health system which must be measured and monitored over time [Reference Mirzoev and Kane19]. More specifically, health system responsiveness encompasses both the system’s ability and capacity to respond and its actual response to medical [Reference Khan, Kagwanja, Whyle, Gilson, Molyneux and Schaay20] and nonmedical issues [18].

In particular, Scandinavian countries, such as Sweden (10), Denmark (8.8), and Finland (8.3), showed the best performance in responsiveness in healthcare, while Romania (1.0), Slovakia (1.1), and Latvia and Bulgaria (1.2) had the poorest results. Specifically, four major domains of healthcare systems across Europe were evaluated, namely workforce, facilities, quality of care, and economic resources.

Regarding workforce, Finland (10), the Netherlands (9.7), and Denmark (8.3) achieved the best performance, while Bulgaria (1.0), Portugal (1.9), and Romania (2.0) showed the lowest scores. As of 2021, on average, for the EU-27 + UK countries, there were 18.8 psychiatrists per 100,000 inhabitants, ranging from 10.2 (Bulgaria) to 28.6 (Germany), that is, an almost threefold variation. Two countries – Spain and Malta – had no child psychiatrists at all. Such a high variability of healthcare professionals’ rates across European countries may have widened since the coronavirus disease 2019 (COVID-19) pandemic [2Reference Lora, Kohn, Levav, McBain, Morris and Saxena4]. Of concern, there has been a severe shortage of MH professionals as the number of individuals in need increased, which seems to be exacerbated by high levels of staff burnout [Reference O’Connor, Muller Neff and Pitman21]. Thus, it is estimated that by 2030, Europe will face a shortfall of ~600,000 doctors [22]. Although Digital Mental Health approaches may mitigate this [Reference Moreno, Wykes, Galderisi, Nordentoft, Crossley and Jones23Reference Wies, Landers and Ienca25], their long-term outcomes remain unknown [Reference Cummings, Zhang, Gandré, Morsella, Shields-Zeeman and Winkelmann26]. Therefore, urgent action is needed to enhance staff recruitment and retention rates across Europe [22].

In terms of facilities, Slovenia (10), Italy (9.9), and Cyprus (9.6) were the most resourced countries, whereas the Netherlands (1.0), Germany (1.5), and Belgium (3.4) had the poorest performance. Given the Headway Initiative methodology [15], results of worse-performing countries may only indicate a better provision of inpatient, rather than community-based MH facilities, and not necessarily limited MH facilities.

In keeping with the above, mental healthcare expenditure significantly varied across Europe, with France (13.9%), Germany (13.1%), and Sweden (10.0%) – all of them with good performance in responsiveness – emerging as the principal investors, significantly exceeding the EU-27 + UK average of 5.4%. Hence, many European countries failed to comply with the 2018 Lancet Commission recommendations, according to which national MH budgets should receive between 5% (low- and middle-income countries) and 10% (high-income countries) of the total healthcare [Reference Patel, Saxena, Lund, Thornicroft, Baingana and Bolton27]. Certainly, greater national MH expenditure was linked to better quality of care in psychiatry [Reference Salisbury, Killaspy and King28], including lower suicide rates [Reference Nordentoft and Erlangsen29]. In addition, MH prevention yields a high long-term return on investment [Reference McDaid, Park and Wahlbeck30].

Regarding quality of care, Denmark (10.0), Ireland (9.4), and Sweden (8.7) showed the highest performance, whereas Romania (1.0), Slovakia (1.4), and Bulgaria and Latvia (1.5) had the poorest quality of care. Despite MH becoming a top priority in the political agenda of European governments and institutions [31], up to 6.2% Europeans reported unmet MH needs due to financial issues in 2022, ranging from 1.1% (Romania) to 29.8% (Finland). [5]. These apparent between-country differences, however, may well reflect the quality of data and reporting issues, including the influence of stigma, which tends to discourage people from talking openly about MH [Reference Thornicroft, Sunkel, Alikhon Aliev, Baker, Brohan and El Chammay11].

Responsiveness in workplaces, schools, and society

Regarding responsiveness in workplaces, Germany (10) and Finland and Belgium (9.4) reached the best performance, while Greece (1.0), Slovakia (1.4), and Czechia and Hungary (3.4) had the lowest scores. Overall, almost two in three Europeans with mental disorders were found to be unemployed and get paid, on average, 30% lower wages than their counterparts. Indeed, MH patients face exclusion from work, largely due to stigma and discrimination, which prevents them from recovery [Reference Thornicroft, Sunkel, Alikhon Aliev, Baker, Brohan and El Chammay11, 32]. Labour market integration policies should be promoted [Reference Curtis, Pearce, Cherrie, Dibben, Cunningham and Bambra33, Reference Hammarström, Westerlund, Janlert, Virtanen, Ziaei and Östergren34], which also reduced suicide risk [Reference Gerdtham and Johannesson35], while community-based mental healthcare effects on return-to-work outcomes are less clear [Reference Lundqvist, Brattmyr, Lindberg, Havnen, Solem and Hjemdal36]. Although the WHO developed specific guidelines on MH promotion at work [37], guidelines compliance and their effects on health and social outcomes remain to be established [Reference Malik, Ayuso-Mateos, Baranyi, Barbui, Thornicroft and van Ommeren38].

In terms of responsiveness in schools, France (10.0) and Latvia and Lithuania (8.6) achieved the best performance, whereas Slovakia (1.0), Cyprus (2.2) and Greece (2.4) had the poorest results. It is well-established that for almost two in three MH patients, the illness onset occurs before age 25 years, with a peak at 14.5 years [Reference Solmi, Radua, Olivola, Croce, Soardo and Salazar de Pablo39]. In Europe, full-time compulsory education/training usually lasts 10–11 years and ends at the age of 15–16 years [40]. Our results revealed that the overall performance on responsiveness in schools negatively correlated with the overall MH status and suicide rates – the better the performance at schools, the poorer the MH status, including higher suicide rates. However, up to 20% of European children were shown to experience MH problems during their school years, and a comparable proportion reported feelings of unhappiness and anxiety about the future, which was linked to bullying, challenging schoolwork and loneliness [5]. In addition, EU Countries widely differed in the ability to provide MH prevention and promotion programs at schools, and between 7.5% (Estonia) and up to 21.5% (The Netherlands) of school dropouts were children with mental disorders [41]. Hence, few would question the appropriateness of schools as “the right place at the right time” for early intervention [Reference Fusar-Poli, Correll, Arango, Berk, Patel and Ioannidis12, Reference Arango and Fusar-Poli42]. Consistent with this, targeted prevention programs reduced depression and anxiety symptoms [Reference Werner-Seidler, Spanos, Calear, Perry, Torok and O’Dea43], whereas universal school-based interventions prevented suicidal behaviour in adolescents [Reference Wasserman, Hoven, Wasserman, Wall, Eisenberg and Hadlaczky44]. In addition, school-based MH promotion programs focused on resilience may aid students in managing their own stress [Reference Fenwick-Smith, Dahlberg and Thompson45], which could be delivered through digital technologies [Reference Chen, Ou, Li and Luo46]. MH clinical liaison teams appear to facilitate access to care [Reference Camacho-Rubio, Ulloa, Parellada, Pina-Camacho, Díaz-Caneja C and Sevilla-Cermeño47, Reference McPhail, Thornicroft and Gronholm48], which should result in better long-term outcomes, although this remains to be demonstrated.

Regarding responsiveness in society, Germany (10), France (9.3), and Sweden (8.6) achieved the highest performance, while Greece (1.0), Estonia (2.0), and Romania (3.1) had the poorest performance. Of note, there was a negative association between responsiveness in society, especially MH promotion programs, and MH status – the poorer the MH status, the better the responsiveness. From a societal perspective, stigma and discrimination were identified as the main areas of concern for improving people’s MH [Reference Thornicroft, Sunkel, Alikhon Aliev, Baker, Brohan and El Chammay11]. Stigma was defined as the co-occurrence of stereotyping, separating, status loss, and discrimination in the context of power inequities [Reference Link, Yang, Phelan and Collins49]. While the youth may particularly benefit from antistigma campaigns [Reference Song, Hugh-Jones, West, Pickavance and Mir50], such as the England-based Time-to-Change [Reference Sampogna, Bakolis, Evans-Lacko, Robinson, Thornicroft and Henderson51], especially in the short-term [Reference Sampogna, Bakolis, Evans-Lacko, Robinson, Thornicroft and Henderson51], their long-term effects remain far from clear [Reference Gronholm, Henderson, Deb and Thornicroft52].

Next steps

In the first Headway-based article (Lopez-Morinigo et al., this issue), we examined the MH status of Europeans and its determinants. Interestingly, overall KPI scores on responsiveness in workplaces (r = −0.46, p = .014), schools (r = −0.59, p < .001), and society (r = −0.53, p = .003) negatively correlated with overall KPI scores on MH status – the better the responsiveness, the worse the MH status. On the other hand, the correlation between overall performance in responsiveness in healthcare and MH status did not reach significance (r = −0.34, p = .075). Taken together, these findings deserve some consideration. First, it seems that responsiveness to people’s MH needs may largely occur in workplaces, schools, and society rather than in healthcare systems. Second, there was a negative correlation between MH status and responsiveness – the better the status, the worse the responsiveness. Whether more responsive countries succeeded in meeting preexisting greater MH needs (i.e., a positive result) or they failed to address people’s MH issues (i.e., a negative result) remains to be clarified. Of relevance, overall KPI scores on determinants, which were not linked with MH status KPIs (Lopez-Morinigo et al., this issue), positively correlated with responsiveness in healthcare (r = 0.41, p = .031) and in workplaces (r = 0.40, p = .034). This noted, further theoretical debate about the appropriateness of KPIs for the evaluation of public MH policies is still warranted.

Indeed, the lack of comprehensive, independent, and comparable data poses a major barrier to the development of a monitoring and evaluation/accountability framework in MH policymaking. To address this challenge, within the United Nations Sustainable Development Goals agenda, the Countdown Global Mental Health 2030 was designed, which collected data on 48 indicators from 15 sources covering 193 countries across the globe. Specifically, indicators were clustered around three themes: determinants of MH and factors shaping MH needs and their response [Reference Saxena and Kline53]. Easily-accessible datasets, such as the European Headway Initiative [15] and the Countdown Global Mental Health [Reference Saxena and Kline53], may inform public MH policymaking, including between-country comparisons, whereas researchers may generate novel real-world hypotheses. However, these data-driven approaches are not exempt from criticism, namely the extent to which somehow arbitrarily chosen KPIs really align with the population MH needs and the time required to evaluate MH policy changes.

In particular, this study’s results may contribute to future evidence-based MH policies aimed to address European-level and country-specific challenges. To this end, scientific societies, such as the European Psychiatric Association (EPA) and the World Psychiatric Association (WPA), are committed to providing a strong leadership. This being said, it is worth noting that more than nine in 10 healthcare interventions subject to Cochrane Reviews were not supported by high-quality evidence, while harms do not tend to get published [Reference Howick, Koletsi, Ioannidis, Madigan, Pandis and Loef54]. In addition, health authorities must bridge the gap between research evidence, clinical guideline recommendations, and approved interventions by regulatory bodies, especially in children and adolescents with serious mental illness [Reference Lopez-Morinigo, Leucht and Arango55, Reference Solerdelcoll, Arango and Sugranyes56].

Of relevance, MH policymaking is not exempt from compliance with international codes of ethics in psychiatry [Reference Galderisi, Appelbaum, Gill, Gooding, Herrman and Melillo57]. To this end, the ongoing dialogue between the EPA and the WPA [Reference Sansone, Tyano, Melillo, Schouler-Ocak and Galderisi58] and closer collaboration between national psychiatric associations [Reference Samochowiec, Frydecka, Skonieczna-Żydecka, Schouler-Ocak, Carpinello and Chkonia59] will be essential. Digital MH raises ethical issues about privacy and the use of personal data, which is particularly relevant to children and adolescents [Reference Cratsley and Radden60]. More broadly speaking, public MH also faces the challenge of appropriately timing and targeting interventions, which is crucial for staging models [Reference Fusar-Poli, McGorry and Kane61], not to mention the sometimes blurred boundaries between health and disease in MH [Reference Cratsley and Radden60].

To address the increased MH needs after the COVID-19 pandemic, some MH action plans have been made by European governments. For instance, since 2021, the UK government has offered training grants for senior MH leads to all state schools and colleges, whereas in Spain, a 24-h suicide prevention hotline became available that same year. In 2022, MH services in Belgium were reformed to facilitate access to care from schools, sports facilities, and work. One year later, the 2023 German Centre for Mental Health (DZPG) research network was launched. In Italy, since 2023/2024 a psychologist can be accessed both in schools and in primary care (i.e., “Psicologo di base”) [15].

In light of our results, further evidence-based public MH interventions can be recommended. To enhance responsiveness in healthcare systems, not only is higher MH expenditure required, but also optimization of available resources, such as the so-called digital MH [Reference Witteveen, Young, Cuijpers, Ayuso-Mateos, Barbui and Bertolini62]. Labour market integration policies may make the onset of work-related mental disorders less likely [Reference Curtis, Pearce, Cherrie, Dibben, Cunningham and Bambra33, Reference Hammarström, Westerlund, Janlert, Virtanen, Ziaei and Östergren34]. In schools, MH promotion programs [Reference Chen, Ou, Li and Luo46] and clinical liaison teams [Reference McPhail, Thornicroft and Gronholm48] may become the key primary and secondary (i.e., early detection/intervention) preventive strategies, respectively. Finally, from a societal approach, antistigma campaigns should facilitate professional help-seeking by MH patients [Reference Thornicroft, Sunkel, Alikhon Aliev, Baker, Brohan and El Chammay11]. See Table 6 for further details.

Table 6. Interventions on KPIs in responsiveness to mental health needs in healthcare, workplaces, schools, and society

Strengths and limitations

The Headway Initiative collected cross-national population-level data on 54 MH-related KPIs, including MH status and determinants (Lopez-Morinigo et al., this issue) and responsiveness of the systems to the population MH needs. Data came from official, authoritative open-access datasets, such as Eurostat, WHO, or the Organisation for Economic Co-operation and Development (OECD), thus ensuring the replicability of the study. Owing to this methodology, some evidence-based public MH interventions were recommended.

However, three main limitations of this study should be acknowledged. First, the Headway methodology relied on national datasets, which differed in the quality of data and data availability (i.e., under- and overreporting issues), including cross-national cultural differences. Further, data on KPIs were collected in different years depending on data availability, that is, from the most recent year when the variable data were available. In addition, it is worth noting that “association does not mean causation” [Reference Hill63], and caution is needed when inferring causality from the above bivariate correlations. Second, further nontested KPIs, such as psychiatric medication availability and compliance and/or funding source of healthcare systems, may have altered the results. Third, the Headway Initiative adopted both analytical and qualitative approaches, which, although unlikely, may have biased the results. In particular, the Headway Mental Health Index aimed to comparatively measure European countries’ relative performance on a number of MH-related KPIs, thus ranking them rather than cross-comparing raw data on the above variables.

Conclusions

The world is facing an unprecedented MH crisis, which requires a high degree of responsiveness in healthcare systems, but also in workplaces, schools, and society. In this respect, the Headway Mental Health Index proved useful in assessing up to 54 MH-related KPIs across European countries, which may also monitor changes over time. This study’s findings may therefore guide future evidence-based European MH policies.

MH has become a top priority for European institutions [31]. It is therefore in our hands not to miss this unique opportunity to make a change in European MH policymaking. Enhancing our countries’ responsiveness to their citizens’ MH needs will benefit both the current and future generations.

Supplementary material

The supplementary material for this article can be found at http://doi.org/10.1192/j.eurpsy.2025.2448.

Data availability statement

All the data supporting the findings of this study are available in the online Supplementary Material.

Acknowledgments

As noted above, data for this study came from the 2023 “Headway – Mental Health Index 3.0,” which was designed and elaborated by The European House – Ambrosetti. In particular, the authors are very grateful to Daniela Bianco (Partner, The European House – Ambrosetti and Head of Healthcare Practice, TEHA Group), Elisa Milani (“Headway” Project Coordinator and Senior Consultant, The European House – Ambrosetti), Irene Gianotto (Consultant, The European House – Ambrosetti), and Iacopo Del Panta (Analyst, The European House – Ambrosetti) for sharing the data. We are also very grateful to Angelini Pharma for funding the article processing charge.

Author contribution

Conceptualization: Javier-David Lopez-Morinigo, Andrea Fiorillo, Geert Dom, and Celso Arango. Data curation: Javier-David Lopez-Morinigo. Formal analysis: Javier-David Lopez-Morinigo. Methodology: Javier-David Lopez-Morinigo, Andrea Fiorillo, Geert Dom, and Celso Arango. Project administration: Javier-David Lopez-Morinigo and Celso Arango. Supervision: Andrea Fiorillo, Geert Dom, and Celso Arango. Validation: Javier-David Lopez-Morinigo, Andrea Fiorillo, Geert Dom, and Celso Arango. Visualization: Javier-David Lopez-Morinigo, Andrea Fiorillo, Geert Dom, and Celso Arango. Writing – original draft: Javier-David Lopez-Morinigo. Writing – review and editing: Javier-David Lopez-Morinigo, Andrea Fiorillo, Geert Dom, and Celso Arango.

Financial support

This research received no specific grant from any funding agency, commercial, or not-for-profit sectors.

Competing interests

Javier-David Lopez-Morinigo, Andrea Fiorillo, and Geert Dom declare no conflicts of interest. Celso Arango has been a consultant to or has received honoraria or grants from Acadia, Angelini, Biogen, Boehringer, Gedeon Richter, Janssen Cilag, Lundbeck, Medscape, Menarini, Minerva, Otsuka, Pfizer, Roche, Sage, Servier, Shire, Schering Plough, Sumitomo Dainippon Pharma, Sunovion, and Takeda.

References

GBD 2019 Mental Disorders Collaborators . Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet Psychiatry. 2022;9:137–50. https://doi.org/10.1016/S2215-0366(21)00395-3.Google Scholar
World Health Organization. World mental health report: transforming mental health for all. World Health Organization; 2022.Google Scholar
Kohn, R, Saxena, S, Levav, I, Saraceno, B. The treatment gap in mental health care. Bull World Health Organ. 2004;82:858–66.Google Scholar
Lora, A, Kohn, R, Levav, I, McBain, R, Morris, J, Saxena, S. Service availability and utilization and treatment gap for schizophrenic disorders: a survey in 50 low- and middle-income countries. Bull World Health Organ. 2012;90:4754, 54A–54B. https://doi.org/10.2471/BLT.11.089284.Google Scholar
European Commission. Flash Eurobarometer on mental health. European Commission; 2023.Google Scholar
Olesen, J. From fragmentation to collaboration in European brain research: the early history of the European Brain Council (EBC), an organization that changed our perspective of advocacy. Eur J Neurol. 2024;31:e16130. https://doi.org/10.1111/ene.16130.Google Scholar
Kirkbride, JB, Anglin, DM, Colman, I, Dykxhoorn, J, Jones, PB, Patalay, P, et al. The social determinants of mental health and disorder: evidence, prevention and recommendations. World Psychiatry. 2024;23:5890. https://doi.org/10.1002/wps.21160.Google Scholar
Park, DS, Han, J, Torabi, M, Forget, EL. Managing mental health: why we need to redress the balance between healthcare spending and social spending. BMC Public Health. 2020;20:393. https://doi.org/10.1186/s12889-020-08491-1.Google Scholar
Henderson, C, Potts, L, Robinson, EJ. Mental illness stigma after a decade of time to change England: inequalities as targets for further improvement. Eur J Public Health. 2020;30:526–32. https://doi.org/10.1093/eurpub/ckaa013.Google Scholar
Pescosolido, BA, Halpern-Manners, A, Luo, L, Perry, B. Trends in public stigma of mental illness in the US, 1996–2018. JAMA Netw Open. 2021;4:e2140202. https://doi.org/10.1001/jamanetworkopen.2021.40202.Google Scholar
Thornicroft, G, Sunkel, C, Alikhon Aliev, A, Baker, S, Brohan, E, El Chammay, R, et al. The lancet commission on ending stigma and discrimination in mental health. Lancet. 2022;400:1438– 80. https://doi.org/10.1016/S0140-6736(22)01470-2.Google Scholar
Fusar-Poli, P, Correll, CU, Arango, C, Berk, M, Patel, V, Ioannidis, JPA. Preventive psychiatry: a blueprint for improving the mental health of young people. World Psychiatry. 2021;20:200–21. https://doi.org/10.1002/wps.20869.Google Scholar
Priebe, S, Reininghaus, U. Public mental health – a challenge for local communities and research. Psychol Med. 2024;54:13. https://doi.org/10.1017/S0033291724001478.Google Scholar
Mental health atlas 2020. 1st ed. Geneva: World Health Organization; 2021.Google Scholar
The European House-Ambrosetti. Headway – Mental Health Index. A new roadmap in mental health; 2023.Google Scholar
Fiorillo, A, Gorwood, P. The consequences of the COVID-19 pandemic on mental health and implications for clinical practice. Eur Psychiatr. 2020;63:e32. https://doi.org/10.1192/j.eurpsy.2020.35.Google Scholar
Jones, L, Ventevogel, P. From exception to the norm: how mental health interventions have become part and parcel of the humanitarian response. World Psychiatry. 2021;20:23. https://doi.org/10.1002/wps.20808.Google Scholar
World Health Organization. The world health report 2000. Geneva: WHO; 2000.Google Scholar
Mirzoev, T, Kane, S. What is health systems responsiveness? Review of existing knowledge and proposed conceptual framework. BMJ Glob Health. 2017;2:e000486. https://doi.org/10.1136/bmjgh-2017-000486.Google Scholar
Khan, G, Kagwanja, N, Whyle, E, Gilson, L, Molyneux, S, Schaay, N, et al. Health system responsiveness: a systematic evidence mapping review of the global literature. Int J Equity Health. 2021;20:112. https://doi.org/10.1186/s12939-021-01447-w.Google Scholar
O’Connor, K, Muller Neff, D, Pitman, S. Burnout in mental health professionals: a systematic review and meta-analysis of prevalence and determinants. Eur Psychiatry. 2018;53:7499. https://doi.org/10.1016/j.eurpsy.2018.06.003.Google Scholar
World Health Organization. Regional office for Europe. Health and care workforce in Europe: time to act. Copenhagen: World Health Organization. Regional Office for Europe; 2022.Google Scholar
Moreno, C, Wykes, T, Galderisi, S, Nordentoft, M, Crossley, N, Jones, N, et al. How mental health care should change as a consequence of the COVID-19 pandemic. Lancet Psychiatry. 2020;7:813–24. https://doi.org/10.1016/S2215-0366(20)30307-2.Google Scholar
Torous, J, Wykes, T. Opportunities from the coronavirus disease 2019 pandemic for transforming psychiatric care with telehealth. JAMA Psychiatry. 2020;77:1205–6. https://doi.org/10.1001/jamapsychiatry.2020.1640.Google Scholar
Wies, B, Landers, C, Ienca, M. Digital mental health for young people: a scoping review of ethical promises and challenges. Front Digit Health. 2021;3:697072. https://doi.org/10.3389/fdgth.2021.697072.Google Scholar
Cummings, JR, Zhang, X, Gandré, C, Morsella, A, Shields-Zeeman, L, Winkelmann, J, et al. Challenges facing mental health systems arising from the COVID-19 pandemic: evidence from 14 European and North American countries. Health Policy. 2023;136:104878. https://doi.org/10.1016/j.healthpol.2023.104878.Google Scholar
Patel, V, Saxena, S, Lund, C, Thornicroft, G, Baingana, F, Bolton, P, et al. The Lancet commission on global mental health and sustainable development. Lancet. 2018;392:1553–98. https://doi.org/10.1016/S0140-6736(18)31612-X.Google Scholar
Salisbury, TT, Killaspy, H, King, M. Relationship between national mental health expenditure and quality of care in longer-term psychiatric and social care facilities in Europe: cross-sectional study. Br J Psychiatry. 2017;211:45–9. https://doi.org/10.1192/bjp.bp.116.186213.Google Scholar
Nordentoft, M, Erlangsen, A. Suicide-turning the tide. Science. 2019;365:725. https://doi.org/10.1126/science.aaz1568.Google Scholar
McDaid, D, Park, A-L, Wahlbeck, K. The economic case for the prevention of mental illness. Annu Rev Public Health. 2019;40:373–89. https://doi.org/10.1146/annurev-publhealth-040617-013629.Google Scholar
European Commission. A comprehensive approach to mental health. European Commission; 2023.Google Scholar
NICE. Rehabilitation for adults with complex psychosis. London: National Institute for Health and Care Excellence; 2020.Google Scholar
Curtis, S, Pearce, J, Cherrie, M, Dibben, C, Cunningham, N, Bambra, C. Changing labour market conditions during the “great recession” and mental health in Scotland 2007–2011: an example using the Scottish Longitudinal Study and data for local areas in Scotland. Soc Sci Med. 2019;227:19. https://doi.org/10.1016/j.socscimed.2018.08.003.Google Scholar
Hammarström, A, Westerlund, H, Janlert, U, Virtanen, P, Ziaei, S, Östergren, P-O. How do labour market conditions explain the development of mental health over the life-course? A conceptual integration of the ecological model with life-course epidemiology in an integrative review of results from the Northern Swedish Cohort. BMC Public Health. 2024;24:1315. https://doi.org/10.1186/s12889-024-18461-6.Google Scholar
Gerdtham, U-G, Johannesson, M. Business cycles and mortality: results from Swedish microdata. Soc Sci Med. 2005;60:205–18. https://doi.org/10.1016/j.socscimed.2004.05.004.Google Scholar
Lundqvist, J, Brattmyr, M, Lindberg, MS, Havnen, A, Solem, S, Hjemdal, O. Examination of the knowledge gap of return-to-work outcomes in routine outpatient treatment for common mental disorders: a systematic review. Front Psychol. 2023;14:1167058. https://doi.org/10.3389/fpsyg.2023.1167058.Google Scholar
World Health Organization. WHO guidelines on mental health at work. Geneva: World Health Organization; 2022.Google Scholar
Malik, A, Ayuso-Mateos, JL, Baranyi, G, Barbui, C, Thornicroft, G, van Ommeren, M, et al. Mental health at work: WHO guidelines. World Psychiatry. 2023;22:331–2. https://doi.org/10.1002/wps.21094.Google Scholar
Solmi, M, Radua, J, Olivola, M, Croce, E, Soardo, L, Salazar de Pablo, G, et al. Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies. Mol Psychiatry. 2022;27:281–95. https://doi.org/10.1038/s41380-021-01161-7.Google Scholar
European Commission. European Education and Culture Executive Agency. Education policy. European Commission; 2023.Google Scholar
OECD. Fit mind, Fit job: from evidence to practice in mental health and work. OECD; 2015. https://doi.org/10.1787/9789264228283-en.Google Scholar
Arango, C, Fusar-Poli, P. Primary prevention in psychiatry is not science fiction. Eur Neuropsychopharmacol. 2022;65:30–2. https://doi.org/10.1016/j.euroneuro.2022.09.008.Google Scholar
Werner-Seidler, A, Spanos, S, Calear, AL, Perry, Y, Torok, M, O’Dea, B, et al. School-based depression and anxiety prevention programs: an updated systematic review and meta-analysis. Clin Psychol Rev. 2021;89:102079. https://doi.org/10.1016/j.cpr.2021.102079.Google Scholar
Wasserman, D, Hoven, CW, Wasserman, C, Wall, M, Eisenberg, R, Hadlaczky, G, et al. School-based suicide prevention programmes: the SEYLE cluster-randomised, controlled trial. Lancet 2015;385:1536–44. https://doi.org/10.1016/S0140-6736(14)61213-7.Google Scholar
Fenwick-Smith, A, Dahlberg, EE, Thompson, SC. Systematic review of resilience-enhancing, universal, primary school-based mental health promotion programs. BMC Psychol. 2018;6:30. https://doi.org/10.1186/s40359-018-0242-3.Google Scholar
Chen, T, Ou, J, Li, G, Luo, H. Promoting mental health in children and adolescents through digital technology: a systematic review and meta-analysis. Front Psychol. 2024;15:1356554. https://doi.org/10.3389/fpsyg.2024.1356554.Google Scholar
Camacho-Rubio, J, Ulloa, Á, Parellada, M, Pina-Camacho, L, Díaz-Caneja C, M., Sevilla-Cermeño, L, et al. The mental health clinical liaison programme for schools: developing a new approach in child and adolescent mental healthcare in Spain. Int Rev Psychiatry. 2024:111. https://doi.org/10.1080/09540261.2024.2409187.Google Scholar
McPhail, L, Thornicroft, G, Gronholm, PC. Help-seeking processes related to targeted school-based mental health services: systematic review. BMC Public Health. 2024;24:1217. https://doi.org/10.1186/s12889-024-18714-4.Google Scholar
Link, BG, Yang, LH, Phelan, JC, Collins, PY. Measuring mental illness stigma. Schizophr Bull. 2004;30:511–41. https://doi.org/10.1093/oxfordjournals.schbul.a007098.Google Scholar
Song, N, Hugh-Jones, S, West, RM, Pickavance, J, Mir, G. The effectiveness of anti-stigma interventions for reducing mental health stigma in young people: a systematic review and meta-analysis. Glob Ment Health (Camb). 2023;10:e39. https://doi.org/10.1017/gmh.2023.34.Google Scholar
Sampogna, G, Bakolis, I, Evans-Lacko, S, Robinson, E, Thornicroft, G, Henderson, C. The impact of social marketing campaigns on reducing mental health stigma: results from the 2009–2014 time to change programme. Eur Psychiatry. 2017;40:116–22. https://doi.org/10.1016/j.eurpsy.2016.08.008.Google Scholar
Gronholm, PC, Henderson, C, Deb, T, Thornicroft, G. Interventions to reduce discrimination and stigma: the state of the art. Soc Psychiatry Psychiatr Epidemiol. 2017;52:249–58. https://doi.org/10.1007/s00127-017-1341-9.Google Scholar
Saxena, S, Kline, S. Countdown global mental health 2030: data to drive action and accountability. Lancet Psychiatry. 2021;8:941–2. https://doi.org/10.1016/S2215-0366(21)00391-6.Google Scholar
Howick, J, Koletsi, D, Ioannidis, JPA, Madigan, C, Pandis, N, Loef, M, et al. Most healthcare interventions tested in Cochrane Reviews are not effective according to high quality evidence: a systematic review and meta-analysis. J Clin Epidemiol. 2022;148:160–9. https://doi.org/10.1016/j.jclinepi.2022.04.017.Google Scholar
Lopez-Morinigo, J-D, Leucht, S, Arango, C. Pharmacological treatment of early-onset schizophrenia: a critical review, evidence-based clinical guidance and unmet needs. Pharmacopsychiatry. 2022;55:233–45. https://doi.org/10.1055/a-1854-0185.Google Scholar
Solerdelcoll, M, Arango, C, Sugranyes, G. Calling for the integration of children’s mental health and protection into COVID-19 responses. Rev Psiquiatr Salud Ment (Engl Ed). 2021;14:113–6. https://doi.org/10.1016/j.rpsmen.2021.02.002.Google Scholar
Galderisi, S, Appelbaum, PS, Gill, N, Gooding, P, Herrman, H, Melillo, A, et al. Ethical challenges in contemporary psychiatry: an overview and an appraisal of possible strategies and research needs. World Psychiatry. 2024;23:364–86. https://doi.org/10.1002/wps.21230.Google Scholar
Sansone, N, Tyano, S, Melillo, A, Schouler-Ocak, M, Galderisi, S. Comparing the world psychiatric association and European psychiatric association codes of ethics: discrepancies and shared grounds. Eur Psychiatry. 2024;67:e38. https://doi.org/10.1192/j.eurpsy.2024.1748.Google Scholar
Samochowiec, J, Frydecka, D, Skonieczna-Żydecka, K, Schouler-Ocak, M, Carpinello, B, Chkonia, E, et al. Ethical dilemmas in contemporary psychiatry: findings from a survey of national psychiatric associations in Europe. Eur Psychiatry. 2023;66:e94. https://doi.org/10.1192/j.eurpsy.2023.2470.Google Scholar
Cratsley, K, Radden, J. Public mental health ethics. Lancet Psychiatry. 2022;9:855–6. https://doi.org/10.1016/S2215-0366(22)00273-5.Google Scholar
Fusar-Poli, P, McGorry, PD, Kane, JM. Improving outcomes of first-episode psychosis: an overview. World Psychiatry 2017;16:251–65. https://doi.org/10.1002/wps.20446.Google Scholar
Witteveen, AB, Young, S, Cuijpers, P, Ayuso-Mateos, JL, Barbui, C, Bertolini, F, et al. Remote mental health care interventions during the COVID-19 pandemic: an umbrella review. Behav Res Ther. 2022;159:104226. https://doi.org/10.1016/j.brat.2022.104226.Google Scholar
Hill, AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295300.Google Scholar
Figure 0

Table 1. KPIs in responsiveness to mental health needs in healthcare across European countries

Figure 1

Table 2. Responsiveness to mental health needs in workplaces, schools, and society

Figure 2

Table 3. Headway initiative scores on key performance indicators in responsiveness in healthcare

Figure 3

Table 4. Headway-transformed KPI scores in responsiveness in workplaces, society, and schools

Figure 4

Table 5. Relationship between mental health status and responsiveness across EU-27 + UK countries

Figure 5

Figure 1. Overall results from the 2023 Headway Mental Health Index 3.0.

Figure 6

Table 6. Interventions on KPIs in responsiveness to mental health needs in healthcare, workplaces, schools, and society

Supplementary material: File

Arango et al. supplementary material

Arango et al. supplementary material
Download Arango et al. supplementary material(File)
File 76 KB
Submit a response

Comments

No Comments have been published for this article.